In a perspective blind study of 147 survivors of my* cardial infarction, the 13 patients who had definite recurrent infarction during 38.1 + 7.2 montbs (midmum, 34 months) of follow-up had higher plasma fibrinogen levels (334.4 + 13.1 mg/dl vs 291.5 + 4.7 mg/dl; P=O.OOSS), and higher maximum rate of fibrin growth (generation of turbidity) when m e m d q prothrombi time (IT Vmax, 7.76 However, relatively little attention has been paid to hemostasis as it relates to coronary thrombosis. Retrospective studies of blood coagulation after myoc.ardia1 infarction do not clearly distinguish between changes resulting from the infarction and preexisting hemostatic alterations that contribute to coronary thrombosis.s10 Recently, Meade and co-workers" in a prospective study found associations between death from cardiovascular disease and high levels of factor 7c, factor 8c, and fibrinogen. This article reports an association of increased fibrinogen and increased maximum rate of fibrin growth with reinfarction in a prospective study of 147 survivors of acute myocardial infarction participating in the aspirin myocardial infarction study.12
However, relatively little attention has been paid to hemostasis as it relates to coronary thrombosis. Retrospective studies of blood coagulation after myoc.ardia1 infarction do not clearly distinguish between changes resulting from the infarction and preexisting hemostatic alterations that contribute to coronary thrombosis.s10 Recently, Meade and co-workers" in a prospective study found associations between death from cardiovascular disease and high levels of factor 7c, factor 8c, and fibrinogen. This article reports an association of increased fibrinogen and increased maximum rate of fibrin growth with reinfarction in a prospective study of 147 survivors of acute myocardial infarction participating in the aspirin myocardial infarction study .12 One hundred sixty-two survivors of definite m>ocardial infarction (152 men and ten women, aged 32 to 68 years, mean 52 years) were enrolled in the study three to 58 (23. 23 .4 + 15.6 months after the qualifying infarction). Blood was collected into citrated (3.8 percent) vacuum hibes and centrifuged at nostics Systems, Inc, on e Bio Data P d l e r CP-7 (Bio Data Corp). The maximum rate of fibrin growth was measured as the maximum rate of turbidity generation. The turbidity was obtained from the Profiler CA-7 recording, while clotting assays were performed (Vmax from PT, AP'IT, and m . 1 3 Fibrinogen was measured the next day by the method of Blomback and Blomback'4 harvesting the clot by centrifugation at 27,700 g for 20 minutes. Antithrombin 3 was assayed on frozen-thawed samples within seven days using the Ortho Antithrombin 3 kit. Lysis times were performed according to the CLUE procedurels using urokinase (200 p/ml) and a Biodata PAP-2A instrument.
The coefficient of variation for replicate measurements of the same sample (N-304) was 1.5 percent for fibrinogen, 4.4 percent for APTT Vmax, 4.7 percent for PT Vmax, and 5.4 percent for TT Vmax. The coefficient of variation for blood samples drawn on the same patient three months apart (N=145) were 1.7 percent for fibrinogen, 12.4 percent for APTT Vmax, 11.8 percent for PT Vmax, and 11.0 percent for TT Vmax. Analysis using the values obtained at the first or second measurements yielded similar results. The results of clotting assays were not revealed to the investigators until the end of the study and the completion of classification of all reinfarctions by an independent committee.
During follow-up, 13 patients had definite reinfarction, three had definite stroke, and nine died. Of the seven deaths due to cardiovascular causes, six occurred within 24 hours of the onset of syrnptoms (three within one hour) and were classified as sudden deaths. In only one patient was a definite recurrent myocardial infarction diagnosed before death. Definite pulmonary embolism was not diagnosed in any patient. Patients who had reinfarction had higher fibrinogen levels (334.4 + 13.1 mg/dl vs 291.5 f 4.7 mg/dl; P =0.0055), PT Vmax were PT Vmax (Fig 2) , AP'IT Vmax, and TT Vmax tion parameters and age, sex, blood pressure, hemawere constructed, and the corresponding regression tocrit, history of angina, use of coffee or alcohol.
equations estimated. For each patient (one point signs or symptoms of congestive heart failure, in Fig 2) the difference between the value of Vmax presence of Q waves or ST depression on the ECGs, predicted from fibrinogen using the regression line or the number, age, site, or severity of previous inand the actual value of Vmax was calculated. These farctions. Serum cholesterol values were positively differences (Vmax residuals) had a positive value associated with fibrinogen ( r = 0.31, P = 0.005), Fig 2 ) when the actual Vmax was higher A P l T Vmax ( r = 0.24, P = 0.007), and PT Vmax than that predicted by fibrinogen for a given patient (r=O.22, P=0.01) and was negatively associated and a negative value (eg, Rn in Fig 2) when the actual Vmax was less than that predicted by fibrinogen. Patients who had reinfarction had larger positive PT Vmax residuals ( P = 0.018), APTT Vmax residuals ( P = 0.006 ) , and TT Vmax residuals ( P = 0.05). Eight of 13 reinfarctions occurred in the quartile with the most positive AP' IT Vmax residuals ( risk ratio, 4.8 ) , seven in the quartile with most positive PT Vmax residuals (risk ratio, 3.4), and six in the quartile with the highest positive TI' Vmax residuals (risk ratio, 2.5). Consequently, patients with reinfarction tended to cluster above the regression line in the scatter plots (Fig 2) . Strong, positive, correlations among Vmax residuals were observed ( r = 0.45 to 0.75; P<0.0001) .
An association of cardiovascular mortality and hemostasis was seen in the early results of the Northwick Park prospective heart study.ll Higher levels of factor 7, factor 8, and fibrinogen were measured in men who subsequently died from cardiovascular disease. The findings pertaining to nonfatal myocardial infarction have not been published. A strong association of recurrent nonfatal myocardial infarction with high levels of fibrinogen, and increased maximum rates of fibrin growth (turbidity production when measuring APTT, PT, or I T ) was observed in this prospective study of survivors of a myocardial infarction. The lack of association between coronary mortality and coagulation parameters may be due to the fact that the majority of deaths in this study were sudden deaths. Different pathogenic mechanisms underlie sudden death and myocardial infarction, since occlusive coronary thrombi are rare in the former condition and common in the latter.13*16*17 In either instance, a decrease of coronary blood flow in areas of coronary stenosis may be initiated by platelet aggregation,18*lg coronary s p a~m ,~~~~l or other influences and may lead to angina, arrhythmia, or sudden death. If the decrease of coronary flow is of long duration and the hemostatic mechanisms are enhanced, a fibrin clot leading to a transmural infarction may be produced. In the absence of enhanced hernostasis or a prolonged decrease of coronary flow, the spasm or platelet aggregates are reversed, and a transmural myocardial infarction does not take place. It is, therefore, interesting that hemostatic factors associated with or describing the speed of clot formation ( fibrinogen, Vmax ) were associated with reinfarction in this study.
It is unlikely that the changes in hemostatic function associated with reinfarction were due to the previous ( qualifying ) infarction, since the changes did not correlate with the age, number, and severity of previous infarctions and since the average age of the qualrfying infarction at the beginning of the study was 23 months. Fibrinogen levels increase after myocardial infarction, but return to normal within a year.4 Elevated fibrinogen levels may predispose to infarction by enhancing thrombus formation, by increasing blood viscosity and probably by facilitating the growth of atherosclerotic lesion^.^^^^^ However, reinfarction showed a stronger association with the maximum rate of fibrin growth (Vmax) than with plasma fibrinogen. In addition, Vmax residuals, corrected for fibrinogen level, showed an independent association with recurrent infarction. These two findings suggest that, in addition to fibrinogen, other factors such as factor 7c and & (not measured in this study) may play a role by increasing the quantity and rate of thrombin production which affects V m a~.~~ It is, therefore, possible that increased Vmax may represent the common pathway whereby hemostatic function may predispose to coronary thrombosis.
The association of reinfarction with Vmax measured when testing either the extrinsic pathway (PT Vmax) or the intrinsic pathway ( AP'IT Vmax) is in agreement with the observation of "clusters" of increased hemostatic factors ( fibrinogen, factor 7c, factor 8c) in subjects who died due to cardiovascular disease reported by Meade.ll On the other hand, the high positive correlations among the residuals of APTT Vmax, PT Vmax, and TT Vmax and the association of recurrent infarction with TT Vmax (theoretically not afFected by the intrinsic or extrinsic pathways ) suggest that other factors-g, subtle qualitative differences in fibrinogen or changes in the interaction of fibrinogen with thrombin-may be important.25 Associations of cholesterol with Vmax and fibrinogen and between triglycerides and fibrinogen were found in this and other studies.26v27 However, these blood lipids did not show a strong association with reinfarction. Whatever the underlying mechanisms, this prospective study demonstrates a clear association between definite recurrent myocardial infarction and hemostasis and supports the theory that thrombosis is important in the pathogenesis of coronary artery disease.
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